M Partridge

2.3k total citations
51 papers, 1.8k citations indexed

About

M Partridge is a scholar working on Molecular Biology, Oncology and Otorhinolaryngology. According to data from OpenAlex, M Partridge has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 20 papers in Oncology and 12 papers in Otorhinolaryngology. Recurrent topics in M Partridge's work include Cancer-related Molecular Pathways (12 papers), Head and Neck Cancer Studies (12 papers) and Oral Health Pathology and Treatment (8 papers). M Partridge is often cited by papers focused on Cancer-related Molecular Pathways (12 papers), Head and Neck Cancer Studies (12 papers) and Oral Health Pathology and Treatment (8 papers). M Partridge collaborates with scholars based in United Kingdom, United States and Norway. M Partridge's co-authors include John Langdon, G Emilion, Elaine Phillips, S. Pateromichelakis, J Langdon, Roger A’Hern, S Kiguwa, Rebecca Francis, D E Poswillo and William J. Gullick and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and Journal of Investigative Dermatology.

In The Last Decade

M Partridge

51 papers receiving 1.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M Partridge 759 755 478 346 314 51 1.8k
Maarten P. Tabor 653 0.9× 833 1.1× 826 1.7× 405 1.2× 473 1.5× 11 2.1k
Anita Borges 390 0.5× 599 0.8× 426 0.9× 158 0.5× 476 1.5× 72 1.6k
Franco Ionna 537 0.7× 746 1.0× 509 1.1× 93 0.3× 460 1.5× 99 1.8k
Yolanda Eby 1.3k 1.8× 1.4k 1.8× 907 1.9× 183 0.5× 618 2.0× 21 2.8k
Sen‐Tien Tsai 619 0.8× 570 0.8× 342 0.7× 182 0.5× 459 1.5× 57 1.8k
Pablo Ramos‐García 449 0.6× 375 0.5× 520 1.1× 1.1k 3.2× 368 1.2× 65 1.9k
Lucía González‐Ruiz 296 0.4× 280 0.4× 273 0.6× 555 1.6× 217 0.7× 40 1.1k
Robert Priddy 218 0.3× 240 0.3× 536 1.1× 718 2.1× 320 1.0× 24 1.2k
Ying-Tai Jin 418 0.6× 572 0.8× 169 0.4× 59 0.2× 220 0.7× 33 1.3k
Ángela Ayén 302 0.4× 168 0.2× 211 0.4× 507 1.5× 171 0.5× 17 950

Countries citing papers authored by M Partridge

Since Specialization
Citations

This map shows the geographic impact of M Partridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Partridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Partridge more than expected).

Fields of papers citing papers by M Partridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Partridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Partridge. The network helps show where M Partridge may publish in the future.

Co-authorship network of co-authors of M Partridge

This figure shows the co-authorship network connecting the top 25 collaborators of M Partridge. A scholar is included among the top collaborators of M Partridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Partridge. M Partridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinto, Anna Maria, Roberto Franchini, Rakefet Czerninski, et al.. (2011). Genetics/epigenetics of oral premalignancy: current status and future research*. Oral Diseases. 17(s1). 7–22. 94 indexed citations
2.
Gaballah, Kamis, Richard Oakley, Alice Hills, Anderson J. Ryan, & M Partridge. (2009). The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues. British Journal of Cancer. 101(3). 418–423. 1 indexed citations
3.
Toro-Troconis, Maria, Ulf Mellström, & M Partridge. (2008). Game-based learning in respiratory medicine via Second Life. Thorax. 63. 1 indexed citations
4.
Gaballah, Kamis, Daniela Elena Costea, Alice Hills, et al.. (2008). Tissue engineering of oral dysplasia. The Journal of Pathology. 215(3). 280–289. 14 indexed citations
5.
Partridge, M, et al.. (2007). The changing face of p53 in head and neck cancer. International Journal of Oral and Maxillofacial Surgery. 36(12). 1123–1138. 32 indexed citations
6.
Ali, Ayman, J Langdon, Peter L. Stern, & M Partridge. (2001). The pattern of expression of the 5T4 oncofoetal antigen on normal, dysplastic and malignant oral mucosa. Oral Oncology. 37(1). 57–64. 8 indexed citations
7.
Pateromichelakis, S., et al.. (2000). The FHIT gene in oral squamous cell carcinoma: allelic imbalance is frequent but cDNA aberrations are uncommon. Oral Oncology. 36(2). 180–188. 6 indexed citations
8.
Partridge, M, G Emilion, S. Pateromichelakis, Elaine Phillips, & J Langdon. (1999). Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas. International Journal of Cancer. 83(3). 318–325. 49 indexed citations
9.
Partridge, M, et al.. (1999). The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer. British Journal of Cancer. 79(11/12). 1821–1827. 26 indexed citations
10.
Steingrimsdottir, Herdis, F Elamin, Joop Gäken, et al.. (1999). Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. British Journal of Cancer. 80(1-2). 79–86. 71 indexed citations
11.
Partridge, M, et al.. (1997). Expression of retinoic acid receptors in normal, dysplastic and malignant oral epithelia. British Journal of Oral and Maxillofacial Surgery. 35(4). 260–266. 9 indexed citations
12.
Partridge, M, G Emilion, S. Pateromichelakis, Elaine Phillips, & J Langdon. (1997). Field cancerisation of the oral cavity: Comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions. Oral Oncology. 33(5). 332–337. 60 indexed citations
13.
Gower, N.H., R.M. Rudd, SG Spiro, et al.. (1996). A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial. British Journal of Cancer. 73(12). 1563–1568. 20 indexed citations
14.
Penfold, Christopher N., et al.. (1996). The role of angiogenesis in the spread of oral squamous cell carcinoma. British Journal of Oral and Maxillofacial Surgery. 34(1). 37–41. 56 indexed citations
15.
Partridge, M, S Kiguwa, Y. A. Luqmani, & John Langdon. (1996). Expression of bFGF, KGF and FGF receptors on normal oral mucosa and SCC. European Journal of Cancer Part B Oral Oncology. 32(2). 76–82. 26 indexed citations
16.
Partridge, M & John Langdon. (1995). Oral cancer: a serious and growing problem.. PubMed. 77(5). 321–2. 10 indexed citations
17.
Partridge, M, David Chantry, Martin Turner, & Marc Feldman. (1991). Production of Interleukin-1 and Interleukin-6 by Human Keratinocytes and Squamous Cell Carcinoma Cell Lines. Journal of Investigative Dermatology. 96(5). 771–776. 68 indexed citations
18.
Fagan, Evelyn, et al.. (1987). Review of the herpesviruses and hepatitis A: The potential hazards in dental care. Oral Surgery Oral Medicine Oral Pathology. 64(6). 693–697. 1 indexed citations
19.
Partridge, M, et al.. (1986). Diagnostic techniques for parotid disease. British Journal of Oral and Maxillofacial Surgery. 24(5). 311–322. 15 indexed citations
20.
McIntosh, R. A., M Partridge, & Ray A. Hare. (1980). Telocentric mapping of Sr12 in wheat chromosome 3B.. Cereal Research Communications. 8(2). 321–324. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maarten P. Tabor Breakdown of academic impact, for papers by Anita Borges Breakdown of academic impact, for papers by Franco Ionna Breakdown of academic impact, for papers by Yolanda Eby Breakdown of academic impact, for papers by Sen‐Tien Tsai Breakdown of academic impact, for papers by Pablo Ramos‐García Breakdown of academic impact, for papers by Lucía González‐Ruiz Breakdown of academic impact, for papers by Robert Priddy Breakdown of academic impact, for papers by Ying-Tai Jin Breakdown of academic impact, for papers by Ángela Ayén
Rankless by CCL
2026